Search Funding Opportunities and Notices

 
<--Back to Advanced Search
Search Results
Matching Records: 242
Show: Active Only
Include Notices: Yes No
Expired Active

"NEW" - Now you can save your query and have updated results sent to you periodically. Learn more.

Save this Search

Title FOA/Notice Number Related Issuing Org Released ▼ Opens Expires Activity Code
Post-Stroke Vascular Contributions to Cognitive Impairment and Dementia (VCID) in the United States Including in Health Disparities Populations (U19 Clinical Trial not Allowed)  RFA-NS-19-012  Related  NINDS  02-15-2019  03-17-2019  04-18-2019  U19 
Enhancing Regulatory Science for the Risk Based Quality Assessment of Complex Products (U01) - Clinical Trials Optional  RFA-FD-19-011  Related  FDA  02-13-2019  02-19-2019  04-23-2019  U01 
Cooperative Agreement to Support the Illinois Institute of Technology's Institute for Food Safety and Health (U19 Clinical Trial Optional)  RFA-FD-19-003  Related  FDA  02-12-2019  02-19-2019  04-22-2019  U19 
Functional RNA Modifications Environment and Disease (FRAMED) (R01 Clinical Trial Not Allowed)  RFA-ES-19-001  Related  NIEHS  02-08-2019  04-16-2019  05-17-2019  R01 
Functional RNA Modifications Environment and Disease (FRAMED) (R21 Clinical Trial Not Allowed)  RFA-ES-19-002  Related  NIEHS  02-08-2019  04-16-2019  05-17-2019  R21 
Centers for Medical Countermeasures Against Radiation Consortium (U19 Clinical Trial Not Allowed)  RFA-AI-19-012  Related  NIAID  02-08-2019  04-30-2019  06-01-2019  U19 
Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)  RFA-ES-19-005  Related  NIEHS  02-08-2019  03-09-2019  04-10-2019  R43/R44 
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)  RFA-ES-19-006  Related  NIEHS  02-08-2019  03-09-2019  04-10-2019  R41/R42 
Biological Measures for Prognosing and Monitoring of Persistent Concussive Symptoms in Early and Middle Adolescents: Center Without Walls (PCS-EMA CWOW) (U54 Clinical Trial Not Allowed)  RFA-NS-19-022  Related  NINDS  02-07-2019  03-10-2019  04-11-2019  U54 
Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Not Allowed)  RFA-FD-19-010  Related  FDA  02-07-2019  02-11-2019  04-12-2019  U01 
Bioequivalence of Topical Products: Elucidating the Sensorial and Functional Characteristics of Compositionally Different Topical Formulations (U01 Clinical Trial Required)  RFA-FD-19-009  Related  FDA  02-07-2019  02-11-2019  04-12-2019  U01 
Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed)  RFA-FD-19-008  Related  FDA  02-07-2019  02-11-2019  04-12-2019  U01 
Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required)  RFA-FD-19-014  Related  FDA  02-06-2019  02-06-2019  04-05-2019  U01 
Secondary Data Analysis to Examine Long-Term and/or Potential Cross-Over Effects of Prevention Interventions: What are the Benefits for Preventing Mental Health Disorders? (R01 Clinical Trial Not Allowed)  RFA-MH-20-110  Related  NIMH  02-06-2019  04-02-2019  01-03-2020  R01 
Transformative Research Award for the INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndrome) Project (R01 Clinical Trial Not Allowed)  RFA-OD-19-016  Related  NIH  02-05-2019  02-14-2018  03-15-2019  R01 
Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trials Required)  RFA-OD-19-018  Related  NIH  02-05-2019  02-14-2019  03-15-2019  R61/R33 
INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)  RFA-OD-19-015  Related  NIH  02-05-2019  02-14-2019  03-15-2019  R21 
Refinement and Testing of Interventions to Sustain ADHD Treatment Effects Across Settings and Developmental Transitions (R34 Clinical Trial Required)  RFA-MH-20-100  Related  NIMH  02-04-2019  04-01-2019  11-16-2019  R34 
NCI Awardee Skills Development Consortium: Research Education Short Courses (UE5 Clinical Trial Not Allowed)  RFA-CA-19-010  Related  NCI  02-01-2019  03-01-2019  04-02-2019  UE5 
NCI Awardee Skills Development Consortium: Program Logistics and Evaluation Coordinating Center (U24 Clinical Trial Not Allowed)  RFA-CA-19-011  Related  NCI  02-01-2019  03-01-2019  04-02-2019  U24 
George M. O'Brien Urology Cooperative Research Centers Program (U54 Clinical Trial Optional)  RFA-DK-18-029  Related  NIDDK  01-31-2019  03-24-2019  04-25-2019  U54 
Multidisciplinary K12 Urologic Research (KURe) Career Development Program (K12 Clinical Trial Optional)  RFA-DK-18-027  Related  NIDDK  01-31-2019  03-24-2019  04-25-2019  K12 
Patient Safety Learning Laboratories (2019): Pursuing Safety in Diagnosis and Treatment at the Intersection of Design, Systems Engineering, and Health Services Research (R18)  RFA-HS-19-001  Related  AHRQ  01-31-2019  01-31-2019  04-01-2019  R18 
Computational Models of Immunity (U01 Clinical Trial Not Allowed)  RFA-AI-19-011  Related  NIAID  01-30-2019  05-10-2019  06-11-2019  U01 
High Quality Human Reference Genomes (HQRG) (U01 Clinical Trial Not Allowed)  RFA-HG-19-002  Related  NHGRI  01-30-2019  03-02-2019  04-03-2019  U01 
Human Genome Reference Center (HGRC) (U41 Clinical Trial Not Allowed)  RFA-HG-19-004  Related  NHGRI  01-30-2019  03-02-2019  04-03-2019  U41 
Research and Development for Genome Reference Representations (GRR) (U01 Clinical Trial Not Allowed)  RFA-HG-19-003  Related  NHGRI  01-30-2019  03-02-2019  04-03-2019  U01 
Addressing the Role of Violence on HIV Care and Viral Suppression (R34 Clinical Trial Optional)  RFA-MH-20-202  Related  NIMH  01-29-2019  03-10-2019  04-11-2019  R34 
Addressing the Role of Violence on HIV Care and Viral Suppression (R21 Clinical Trial Optional)  RFA-MH-20-201  Related  NIMH  01-29-2019  03-10-2019  04-11-2019  R21 
Addressing the Role of Violence on HIV Care and Viral Suppression (R01 Clinical Trial Optional)  RFA-MH-20-200  Related  NIMH  01-29-2019  03-10-2019  04-11-2019  R01 
Developmental Centers for Interdisciplinary Research in Benign Urology (P20 Clinical Trial Not Allowed)  RFA-DK-18-028  Related  NIDDK  01-29-2019  03-10-2019  04-11-2019  P20 
Human Three-Dimensional Cell Model Systems for Alzheimer's Disease-Related Dementias (ADRDs) (UG3/UH3 Clinical Trial Not Allowed)  RFA-NS-19-027  Related  NINDS  01-29-2019  02-14-2019  03-15-2019  UG3/UH3 
Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)  RFA-FD-19-002  Related  FDA  01-29-2019  02-04-2019  04-05-2019  U01 
Advanced Clinical Trials to test Artificial Pancreas Device Systems in Type 1 Diabetes (U01 Clinical Trial Required)  RFA-DK-18-025  Related  NIDDK  01-28-2019  03-10-2019  04-11-2019  U01 
Data Coordinating Center for the Advanced Clinical Trials Consortium to Test Artificial Pancreas Device Systems (U24 Clinical Trial Not Allowed)  RFA-DK-18-026  Related  NIDDK  01-28-2019  03-10-2019  04-11-2019  U24 
The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)  RFA-DK-18-024  Related  NIDDK  01-28-2019  03-10-2019  11-21-2019  F99/K00 
Limited Competition for a Connectome Coordination Facility (R24 Clinical Trial Not Allowed)  RFA-MH-20-210  Related  NIMH  01-25-2019  05-24-2019  06-25-2019  R24 
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional)  RFA-HL-20-012  Related  NHLBI  01-25-2019  02-14-2019  04-16-2021  R35 
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)  RFA-HL-20-011  Related  NHLBI  01-25-2019  02-14-2019  04-16-2021  R35 
Mechanistic studies on chronic alcohol use and sleep homeostasis (R01 Clinical Trial Optional)  RFA-AA-19-006  Related  NIAAA  01-24-2019  03-17-2019  04-18-2019  R01 
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)  RFA-CA-19-032  Related  NCI  01-24-2019  07-01-2019  08-04-2020  R01 
HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)  RFA-AI-19-006  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1 Clinical Trial Required)  RFA-AI-19-001  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)  RFA-AI-19-005  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)  RFA-AI-19-004  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1 Clinical Trial Required)  RFA-AI-19-003  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1 Clinical Trial Required)  RFA-AI-19-002  Related  NIAID  01-24-2019  07-01-2019  08-02-2019  UM1 
Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Obesity Research (U01 Clinical Trial Not Allowed)  RFA-DK-19-001  Related  NIDDK  01-23-2019  03-17-2019  04-18-2019  U01 
Establishing a Cohort to Clarify Risk and Protective Factors for Neurocognitive Complications of Pediatric Type 1 Diabetes (T1D) - Planning Cooperative Agreements (U34 Clinical Trial Not Allowed)  RFA-DK-18-007  Related  NIDDK  01-23-2019  03-11-2019  04-12-2019  U34 
Center for Natural Product Technology, Methodology, and Productivity Optimization (NP-TEMPO) (U41 Clinical Trial Not Allowed)  RFA-AT-19-003  Related  NCCIH  (formerly NCCAM) 01-22-2019  03-29-2019  04-30-2019  U41 
Botanical Dietary Supplements Research Centers (U19 Clinical Trial Optional)  RFA-OD-19-001  Related  ODS  01-22-2019  03-15-2019  04-16-2019  U19 
Natural Products NMR Open Data Exchange (NP-NODE) (U24 Clinical Trial Not Allowed)  RFA-AT-19-002  Related  NCCIH  (formerly NCCAM) 01-22-2019  03-01-2019  04-02-2019  U24 
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)  RFA-MD-19-001  Related  NIMHD  01-18-2019  03-01-2019  04-02-2019  R43/R44 
Development of New Technologies and Bioengineering Solutions for the Advancement of Cell Replacement Therapies for Type 1 Diabetes (R43/44 Clinical Trial Not Allowed)  RFA-DK-18-023  Related  NIDDK  01-18-2019  02-21-2019  03-22-2019  R43/R44 
Womens HIV Epidemiology Cohort Studies (R01 Clinical Trial Not Allowed)  RFA-HD-19-024  Related  NICHD  01-16-2019  03-04-2019  05-15-2019  R01 
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R43/R44 - Clinical Trial Optional)  RFA-DA-19-033  Related  NIDA  01-11-2019  02-20-2019  03-21-2019  R43/R44 
Virtual Reality Tools to Enhance Evidence Based Treatment of Substance Use Disorders (R41/R42 - Clinical Trial Optional)  RFA-DA-19-032  Related  NIDA  01-11-2019  02-20-2019  03-21-2019  R41/R42 
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required)  RFA-CA-19-033  Related  NCI  01-11-2019  02-15-2019  01-04-2020  U01 
Limited Competition for the Continuation of the Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)  RFA-DK-18-509  Related  NIDDK  01-10-2019  02-21-2019  03-22-2019  U01 
Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)  RFA-DK-18-008  Related  NIDDK  01-10-2019  02-21-2019  03-22-2019  U01 
The Experimental Therapeutics Clinical Trials Network (UM1 Clinical Trials Required)  RFA-CA-19-007  Related  NCI  01-10-2019  04-22-2019  05-23-2019  UM1 
The Experimental Therapeutics Clinical Trials Network (ETCTN) Pharmacokinetic Resource Laboratories (U24 Clinical Trials Not Allowed)  RFA-CA-19-008  Related  NCI  01-10-2019  04-22-2019  05-23-2019  U24 
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R41/R42 Clinical Trial Optional)  RFA-DA-19-022  Related  NIDA  01-09-2019  02-19-2019  03-20-2019  R41/R42 
Mobile Technologies Extending Reach of Primary Care for Substance-Use-Disorders (R43/R44 Clinical Trial Optional)  RFA-DA-19-021  Related  NIDA  01-09-2019  02-19-2019  03-20-2019  R43/R44 
The Human Biomolecular Atlas Program (HuBMAP): Rapid Implementation of Technologies that Will Accelerate Development of a Framework for Mapping the Human Body at High Resolution (UH3 Clinical Trial Not Allowed)  RFA-RM-19-002  Related  RMOD  01-09-2019  02-14-2019  03-15-2019  UH3 
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)  RFA-CA-19-026  Related  NCI  01-07-2019  02-07-2019  09-28-2019  P01 
Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)  RFA-CA-19-024  Related  NCI  01-07-2019  02-07-2019  09-28-2019  U01 
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)  RFA-CA-19-023  Related  NCI  01-07-2019  02-07-2019  09-28-2019  R01 
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)  RFA-CA-19-027  Related  NCI  01-07-2019  02-07-2019  09-28-2019  P50 
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional)  RFA-CA-19-025  Related  NCI  01-07-2019  02-07-2019  09-28-2019  U54 
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)  RFA-CA-19-028  Related  NCI  01-07-2019  02-07-2019  09-28-2019  U2C 
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)  RFA-CA-19-021  Related  NCI  01-07-2019  02-07-2019  09-28-2019  R21 
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)  RFA-CA-19-020  Related  NCI  01-07-2019  02-07-2019  09-28-2019  R33 
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)  RFA-CA-19-019  Related  NCI  01-07-2019  02-07-2019  09-28-2019  R21 
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)  RFA-CA-19-022  Related  NCI  01-07-2019  02-07-2019  09-28-2019  R33 
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)  RFA-AT-19-009  Related  NCCIH  (formerly NCCAM) 01-03-2019  02-15-2019  03-16-2019  R21 
Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)  RFA-AT-19-008  Related  NCCIH  (formerly NCCAM) 01-03-2019  02-15-2019  03-16-2019  R01 
U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)  RFA-CA-19-009  Related  NCI  01-02-2019  01-21-2019  02-22-2019  R01 
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)  RFA-DA-19-030  Related  NIDA  01-02-2019  02-04-2019  03-05-2019  R41/R42 
Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)  RFA-DA-19-031  Related  NIDA  01-02-2019  02-04-2019  03-05-2019  R43/R44 
Resources for Technology Dissemination (U24 Clinical Trial Not Allowed)  RFA-EB-18-002  Related  NIBIB  12-26-2018  01-27-2019  02-28-2019  U24 
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) (Collaborative R34- Clinical Trial Not Allowed)  RFA-DA-19-029  Related  NIDA  12-21-2018  02-25-2019  03-26-2019  R34 
HEAL Initiative: HEALthy Brain and Child Development Study (HEALthy BCD) ( R34- Clinical Trial Not Allowed)  RFA-DA-19-036  Related  NIDA  12-21-2018  02-25-2019  03-26-2019  R34 
Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders (UG1 Clinical Trial Required)  RFA-DA-19-018  Related  NIDA  12-21-2018  02-15-2019  03-16-2019  UG1 
NEI Audacious Goals Initiative: Preliminary Studies for Translation-Enabling Models of the Visual System (R21 Clinical Trial Not Allowed)  RFA-EY-19-001  Related  NEI  12-20-2018  02-08-2019  03-09-2019  R21 
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed)  RFA-CA-19-029  Related  NCI  12-20-2018  01-26-2019  02-27-2019  K99/R00 
NCI Pathway to Independence Award for Outstanding Early Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required)  RFA-CA-19-030  Related  NCI  12-20-2018  01-26-2019  02-27-2019  K99/R00 
Revision Application for Implementation Research to Inform and Enhance PEPFAR HIV Pre-exposure Prophylaxis (PrEP) Delivery (R01 Clinical Trial Optional)  RFA-MH-19-425  Related  NIMH  12-19-2018  01-18-2019  02-20-2019  R01 
Limited Competition: NeuroImaging Tools and Resources Collaboratory (R24 Clinical Trial Not Allowed)  RFA-EB-18-004  Related  NIBIB  12-18-2018  01-22-2019  02-23-2019  R24 
NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)  RFA-OD-19-014  Related  NIH  12-17-2018  02-19-2019  03-20-2019  U01 
Human Islet Research Network - Consortium on Modeling Autoimmune Interactions (HIRN-CMAI) (U01 Clinical Trial Not Allowed)  RFA-DK-18-013  Related  NIDDK  12-17-2018  01-26-2019  02-27-2019  U01 
NIDCR Mentoring Network to Support a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trials Not Allowed)  RFA-DE-19-007  Related  NIDCR  12-12-2018  04-30-2019  05-31-2019  UE5 
Comprehensive Alcohol-HIV/AIDS Research Center (P60 Clinical Trial Optional)  RFA-AA-19-003  Related  NIAAA  12-11-2018  03-16-2019  04-17-2019  P60 
HEAL Initiative: Preventing Opioid Use Disorder in Older Adolescents and Young Adults (ages 1630) (UG3/UH3 Clinical Trial Required)  RFA-DA-19-035  Related  NIDA  12-10-2018  02-13-2019  03-14-2019  UG3/UH3 
HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)  RFA-TR-19-005  Related  NCATS  12-10-2018  01-28-2019  03-01-2019  UH2/UH3 
HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not Allowed)  RFA-TR-19-003  Related  NCATS  12-10-2018  01-28-2019  03-01-2019  UG3/UH3 
HEAL Initiative: Optimization of Non-addictive Therapies [Small Molecules and Biologics] to Treat Pain - (U44 Clinical Trial Not Allowed)  RFA-NS-19-020  Related  NINDS  12-10-2018  12-09-2018  03-07-2019  U44 
HEAL Initiative: Effectiveness Trials to Optimize, Implement, Scale, and Sustain the Collaborative Care Model for Individuals with Opioid Use Disorders and Mental Health Conditions (U01 Clinical Trial Required)  RFA-MH-19-525  Related  NIMH  12-10-2018  03-01-2019  04-02-2019  U01 
HEAL Initiative: Back Pain Consortium (BACPAC) Research Program Technology Research Sites (UH2/UH3 Clinical Trial Optional)  RFA-AR-19-028  Related  NIAMS  12-10-2018  02-20-2019  03-21-2019  UH2/UH3 
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)  RFA-NS-19-016  Related  NINDS  12-10-2018  12-09-2018  02-23-2021  UG3/UH3 

[ Previous Page / 1 2 3 / Next Page ]

This page last updated on March 26, 2014 
Technical Issues: E-mail OER Webmaster